Arterial Embolization: Clinical Trials

2 trials of Arterial Embolization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Arterial Embolization: new trials by email Literature Review of Arterial Embolization trials Research Report on Arterial Embolization

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
Arterial Embolization, Pembrolizumab, Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate - Metastatic Malignant Neoplasm in the Liver, Neuroendocrine Neoplasm
Phase 2CompletedNicholas Fidelman, MD322018-08-272026-08-28
[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
18F-Fluoromisonidazole, Arterial Embolization, Computed Tomography - Adult Liver Carcinoma, Liver Cirrhosis
Phase 2CompletedStanford University52016-09-132024-01-31

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Liver Cirrhosis (1)  ·  Neuroendocrine Tumors (1)

Sponsors

Nicholas Fidelman, MD (1)  ·  Stanford University (1)

Countries

United States (2)

Top investigators

Nicholas Fidelman, MD (1)  ·  Rajesh Shah (1)

Results publications

PMID 35485937

NIH funding

P30CA124435 (1)